Immunotherapy Drug Fights Early-Stage Lung Cancer

By Dennis Thompson HealthDay Reporter THURSDAY, May 20, 2021 (HealthDay News) — An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report. Atezolizumab reduced by 34% the risk of disease recurrence or death in a certain group of people with stage … Read more